Inflarx Commitment Program News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Inflarx Commitment Program. Real-time updates on events, politics, business and more.

InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators

May 21, 2024

JENA, Germany, May 21, 2024 -- InflaRx N.V. , a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, announced data presented at the American...

San Diego United States Inflarx Gmb Regina Lutz Camilla Chong Laurie Doyle

Source: marketscreener.com

InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for Eligible Patients

January 25, 2024

InflaRx to cover costs of GOHIBIC for patients who are treated in line with its Emergency Use Authorization but do not survive. InflaRx is determined to support broader access to GOHIBIC for eligible...

United States Laurie Doyle Christian Sandrock Regina Lutz Nielsc Riedemann Inflarx Gmb

Source: marketscreener.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Inflarx Commitment Program News Today

InflaRx Presents New Analysis of PANAMO Phase III Trial in Severe COVID-19 at ATS 2024 Showing Potential Synergy With Vilobelimab When Used in Combination with Other Immunomodulators

InflaRx Announces Initiation of its Commitment Program for GOHIBIC&#xAE;(vilobelimab) to Help Broaden Access for Eligible Patients

Explore More Categories

InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for Eligible Patients